ES2133418T3 - Procedimiento para la preparacion de derivados del taxano. - Google Patents
Procedimiento para la preparacion de derivados del taxano.Info
- Publication number
- ES2133418T3 ES2133418T3 ES93924646T ES93924646T ES2133418T3 ES 2133418 T3 ES2133418 T3 ES 2133418T3 ES 93924646 T ES93924646 T ES 93924646T ES 93924646 T ES93924646 T ES 93924646T ES 2133418 T3 ES2133418 T3 ES 2133418T3
- Authority
- ES
- Spain
- Prior art keywords
- radical
- general formula
- bacatine
- saturated
- protected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title abstract 2
- -1 HYDROXY FUNCTION Chemical group 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
PROCESO DE PREPARACION DE DERIVADOS DE TAXANO DE FORMULA GENERAL /(I) POR ESTERIFICACION DE LA BACATINA III PROTEGIDA O DE 10-DESACETIL-BACATINA III PROTEGIDA MEDIANTE UN ACIDO DE FORMULA GENERAL (II). EN LAS FORMULA GENERALES (I) Y (II), AR REPRESENTA UN RADICAL ARILO, R1 Y R2 IDENTICOS O DIFERENTES REPRESENTAN UN ATOMO DE HIDROGENO, UN RADICAL ALCOILO, FENILALCOILO, FENILO, ALCOXIFENILO O DIALCOILSIFENILO, O BIEN R1 Y R2 FORMAN JUNTOS CON EL ATOO DE CARBONO AL QUE ESTAN UNIDOS UN CICLO QUE TIENE DE 4 A 7 ESLABONES, R3 REPRESENTA UN RADICAL ACETILO O UN GRUPO PROTECTOR DE LA FUNCION HIDROXI Y R4 REPRESENTA UN GRUPO PROTECTOR DE LA FUNCION HIDROXI, R REPRESENTA UN RADICAL FENILO O UN RADICAL DE FORMULA R5-O- EN LA QUE R5 REPRESENTA UN RADICAL ALCOILO, ALCENILO, ALCINILO, CICLOALCOILO, CICLOALCENILO, FENILO, HETEROCICLICLO NITROGENADO SATURADO O NO SATURADO. LOS PRODUCTOS DE FORMULA GENERAL (I) SON PARICULARMENTE UTILES PARA PREPARAR EL TAXOL, EL TAXOTERO Y SUS ANALOGOS QUE PRESENTAN PROPIEDADES ANTITUMORALES NOTABLES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9213000A FR2697522B1 (fr) | 1992-10-30 | 1992-10-30 | Procédé de préparation de dérivés du taxane. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2133418T3 true ES2133418T3 (es) | 1999-09-16 |
Family
ID=9435013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93924646T Expired - Lifetime ES2133418T3 (es) | 1992-10-30 | 1993-10-28 | Procedimiento para la preparacion de derivados del taxano. |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US5686623A (es) |
| EP (1) | EP0666857B1 (es) |
| JP (1) | JP3030088B2 (es) |
| KR (1) | KR100255460B1 (es) |
| AT (1) | ATE180258T1 (es) |
| AU (1) | AU679947B2 (es) |
| CA (1) | CA2148103C (es) |
| CZ (1) | CZ287805B6 (es) |
| DE (1) | DE69325031T2 (es) |
| DK (1) | DK0666857T3 (es) |
| ES (1) | ES2133418T3 (es) |
| FI (1) | FI109798B (es) |
| FR (1) | FR2697522B1 (es) |
| GR (1) | GR3030268T3 (es) |
| HU (1) | HUT73780A (es) |
| MX (1) | MX9306606A (es) |
| NO (2) | NO304114B1 (es) |
| NZ (1) | NZ257578A (es) |
| PL (1) | PL177746B1 (es) |
| RU (2) | RU2188198C2 (es) |
| SK (1) | SK281045B6 (es) |
| TW (1) | TW427988B (es) |
| WO (1) | WO1994010169A1 (es) |
| ZA (1) | ZA938012B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9307777A (es) | 1992-12-15 | 1994-07-29 | Upjohn Co | 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. |
| EP0982302B1 (en) * | 1993-06-11 | 2004-04-14 | PHARMACIA & UPJOHN COMPANY | Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them |
| IL127599A (en) * | 1994-01-28 | 2004-06-01 | Upjohn Co | Process for preparing isotaxol analogs |
| CA2170661A1 (en) | 1995-03-22 | 1996-09-23 | John K. Thottathil | Novel methods for the preparation of taxanes using oaxzolidine intermediates |
| EP1099696A3 (en) * | 1995-06-06 | 2001-05-23 | Dr. Reddy's Research Foundation | Preparation of oxazolidine |
| AU4768797A (en) * | 1996-10-24 | 1998-05-15 | Institute Armand-Frappier | A family of canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof |
| US6150537A (en) * | 1997-12-12 | 2000-11-21 | Emory University | Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents |
| EP0982028A1 (en) * | 1998-08-20 | 2000-03-01 | Aventis Pharma S.A. | New use of taxoid derivatives |
| MXPA01001721A (es) * | 1998-08-20 | 2005-06-03 | Aventis Pharma Sa | Nuevo uso de derivados de taxoide. |
| JP4502338B2 (ja) * | 1999-09-17 | 2010-07-14 | 株式会社横浜国際バイオ研究所 | タキソイド化合物の製造法 |
| CA2385528C (en) | 1999-10-01 | 2013-12-10 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| WO2002012216A1 (en) * | 2000-08-08 | 2002-02-14 | Dr. Reddy's Research Foundation | An improved process for the preparation of docetaxel |
| JP2002088935A (ja) | 2000-09-14 | 2002-03-27 | Nichiha Corp | 外装材の縦目地ジョイナー |
| WO2006055837A2 (en) | 2004-11-19 | 2006-05-26 | Dr. Reddy's Laboratories Ltd. | Process for preparing oxazolidine derivatives |
| CZ298332B6 (cs) * | 2005-09-26 | 2007-08-29 | Zentiva, A. S | Zpusob prípravy kyseliny (4S,5R)-2,4-difenyloxazolin-4,5-dihydro-5-karboxylové |
| MX2008008119A (es) * | 2005-12-21 | 2008-09-24 | Tapestry Pharmaceuticals Inc | Procesos para derivados de taxano y compuestos intermedios utiles en los mismos. |
| WO2008074178A1 (fr) * | 2006-11-23 | 2008-06-26 | Shanghai Bailing Pharmaceutical Technology Co., Ltd | Nouveau procédé de préparation de paclitaxel semi-synthétique |
| CN101020672B (zh) * | 2006-12-28 | 2010-08-25 | 上海百灵医药科技有限公司 | 多烯紫杉醇的合成方法 |
| PL388144A1 (pl) | 2009-05-29 | 2010-12-06 | Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością | Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie |
| KR101379694B1 (ko) * | 2011-09-30 | 2014-03-31 | 주식회사 삼양바이오팜 | 탁산유도체의 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2629819B1 (fr) * | 1988-04-06 | 1990-11-16 | Rhone Poulenc Sante | Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii |
| MX9102128A (es) * | 1990-11-23 | 1992-07-08 | Rhone Poulenc Rorer Sa | Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene |
| FR2696458B1 (fr) * | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
| FR2696459B1 (fr) * | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
| FR2696464B1 (fr) * | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III. |
| FR2696460B1 (fr) * | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
| EP0982302B1 (en) * | 1993-06-11 | 2004-04-14 | PHARMACIA & UPJOHN COMPANY | Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them |
-
1992
- 1992-10-30 FR FR9213000A patent/FR2697522B1/fr not_active Expired - Fee Related
-
1993
- 1993-10-25 MX MX9306606A patent/MX9306606A/es not_active IP Right Cessation
- 1993-10-27 ZA ZA938012A patent/ZA938012B/xx unknown
- 1993-10-28 ES ES93924646T patent/ES2133418T3/es not_active Expired - Lifetime
- 1993-10-28 EP EP93924646A patent/EP0666857B1/fr not_active Expired - Lifetime
- 1993-10-28 SK SK557-95A patent/SK281045B6/sk unknown
- 1993-10-28 US US08/424,386 patent/US5686623A/en not_active Expired - Fee Related
- 1993-10-28 CA CA002148103A patent/CA2148103C/fr not_active Expired - Fee Related
- 1993-10-28 AU AU54237/94A patent/AU679947B2/en not_active Ceased
- 1993-10-28 JP JP6510775A patent/JP3030088B2/ja not_active Expired - Lifetime
- 1993-10-28 WO PCT/FR1993/001058 patent/WO1994010169A1/fr not_active Ceased
- 1993-10-28 KR KR1019950701766A patent/KR100255460B1/ko not_active Expired - Fee Related
- 1993-10-28 TW TW082109008A patent/TW427988B/zh not_active IP Right Cessation
- 1993-10-28 CZ CZ19951092A patent/CZ287805B6/cs not_active IP Right Cessation
- 1993-10-28 AT AT93924646T patent/ATE180258T1/de not_active IP Right Cessation
- 1993-10-28 RU RU98103160/04A patent/RU2188198C2/ru not_active IP Right Cessation
- 1993-10-28 HU HU9501235A patent/HUT73780A/hu unknown
- 1993-10-28 PL PL93308638A patent/PL177746B1/pl unknown
- 1993-10-28 NZ NZ257578A patent/NZ257578A/en unknown
- 1993-10-28 DE DE69325031T patent/DE69325031T2/de not_active Expired - Fee Related
- 1993-10-28 DK DK93924646T patent/DK0666857T3/da active
- 1993-10-28 RU RU95111381/04A patent/RU2118958C1/ru not_active IP Right Cessation
-
1995
- 1995-04-26 NO NO951587A patent/NO304114B1/no not_active IP Right Cessation
- 1995-04-28 FI FI952059A patent/FI109798B/fi active
-
1997
- 1997-08-08 US US08/908,807 patent/US6433180B1/en not_active Expired - Fee Related
-
1998
- 1998-04-22 NO NO981813A patent/NO306062B1/no not_active IP Right Cessation
-
1999
- 1999-05-20 GR GR990400398T patent/GR3030268T3/el unknown
-
2002
- 2002-06-26 US US10/179,027 patent/US20030013889A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2095081T3 (es) | Procedimiento para la preparacion de derivados de taxano. | |
| ES2098060T3 (es) | Procedimiento para la preparacion de derivados del taxano. | |
| ES2096329T3 (es) | Procedimiento para la preparacion de derivados del taxano. | |
| MX9306606A (es) | Procedimiento para la preparacion de derivados de taxano. | |
| MX9305764A (es) | Procedimiento para la preparacion de los esteres de la bacatina iii y dela 10-desacetil bacatina iii y productos obtenidos por medio del mismo. | |
| ES2260933T3 (es) | Derivados del acido de tiazolina. | |
| ES2061706T3 (es) | Nuevos 17-aril-esteroides, su procedimiento y productos intermedios de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
| AR004087A1 (es) | Derivado del acido fenilacetico, procedimientos y productos intermedios para su obtencion y las composiciones que los contienen | |
| ES2095059T3 (es) | Productos intermedios en un procedimiento para la purificacion de acido clavulanico. | |
| ES535491A0 (es) | Un metodo de preparar nuevos derivados de benzoil-urea que tienen actividad anti-tumoral | |
| ATE5321T1 (de) | Verfahren zur herstellung derivierter produkte der 7-(2-aryl)-2-hydroxyimino-acetamidocephalosporans[ure. | |
| AR008950A1 (es) | Nuevos compuestos derivados del benzoperhidroisoindol, procedimiento para prepararlos, los intermediarios de sintesis y los procedimientos paraprepararlos, las composiciones farmaceuticas que los contienen, la utilizacion de dichos compuestos para preparar dichas composiciones y las composiciones | |
| ES2101513T3 (es) | Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen. | |
| MX174129B (es) | Procedimiento para la preparacion de nuevos 19-nor-esteroides sustituidos en la posicion 7 y producto obtenido | |
| MX174285B (es) | Agente de conservacion para plantas | |
| PT92180A (pt) | Processo para a preparacao de novas mevalonolactonas do tipo tienopiridina e de composicoes farmaceuticas que as contem | |
| ES2001094A6 (es) | Un procedimiento para la preparacion de un derivado de guanina | |
| AR247205A1 (es) | Procedimiento para la obtencion de compuestos de acidos carboxi-3-alquiloxi-9-oxo-9h-fluoreno o 9h-xanteno alcanoicos y sus sales. | |
| ES8706148A1 (es) | Un procedimiento para preparar nuevos derivados de carbapenem. | |
| ES2131864T3 (es) | Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen. | |
| ES2063156T3 (es) | Nuevos derivados lisogangliosidos. | |
| DE3567201D1 (en) | Derivatives of 3-phenyl-2-propenamine, their preparation and medicines containing them | |
| DK508484A (da) | N-substituerede isoquinolinderivater og farmaceutisk praeparat indeholdende dem | |
| ES2051955T3 (es) | Compuestos azaalifaticos ciclicos con funcion nitroxi, procedimiento para su produccion y medicamentos que contienen estos compuestos. | |
| FI862174A0 (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara berbanderivat. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 666857 Country of ref document: ES |